---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-001042"
form_type: "8-K"
ticker: "AVXL"
cik: "0001314052"
company_name: "ANAVEX LIFE SCIENCES CORP."
filed_at: "2026-08-11T21:00:32+00:00"
generated_at: "2026-08-11T21:02:25.792278+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Anavex files proxy for Sep 24 meeting, adds two independent directors amid PVG proxy fight

## Summary
- 2026 annual meeting set for Sep 24, 2026; record date Jul 31, 2026; PVG owns 0.35% of shares.
- Board nominates Gautam Patel and Dr. Adrian Senderowicz as new independent directors; half of board refreshed.
- Interim CEO Dr. Terrie Kellmeyer leading; blarcamesine advanced in Alzheimer's, Rett, Fragile X with FDA talks.
- Anavex urges votes for six WHITE card nominees; cites PVG slate lacks FDA/drug development expertise.
- Nasdaq delinquency notice for late Q1 10-Q received May 20, 2026; listing unaffected, compliance plan filed.

## SEC filing metadata
- accession: 0001731122-26-001042
- form_type: 8-K
- ticker: AVXL
- cik: 0001314052
- company_name: ANAVEX LIFE SCIENCES CORP.
- filed_at: 2026-08-11T21:00:32+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/0001731122-26-001042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/e7842_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-001042
- JSON: https://secwatch.observer/filing/0001731122-26-001042.json
- Plain text: https://secwatch.observer/filing/0001731122-26-001042.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.